Treatment of Calcified Lesions Using a Dedicated Super-High Pressure Balloon: Multicenter Optical Coherence Tomography Registry.
Natalia Pinilla-Echeverri, Matthias Bossard, Ali Hillani...
https://pubmed.ncbi.nlm.nih.gov/36907698/Actively Recruiting
Led by Luzerner Kantonsspital · Updated on 2024-06-18
280
Participants Needed
1
Research Sites
125 weeks
Total Duration
Researchers are evaluating treatment strategies for patients with acute and chronic coronary artery disease who have severely calcified coronary lesions. These lesions, found in about 10-20% of patients needing revascularization, pose challenges such as higher risks of target lesion failure and stent thrombosis. The study compares two devices used for preparing these calcified lesions before stent placement the super high-pressure OPN17 NC PCI balloon and the Shockwave intravascular lithotripsy IVL balloon catheter. Participants with heavily calcified coronary lesions will be randomly assigned to have their lesions prepared using either the Shockwave IVL catheter or the OPN17 NC balloon. Initial lesion preparation with smaller balloons or rotablation is allowed if needed. After lesion preparation, all patients will receive a latest-generation drug-eluting stent to treat the lesion. The treatment will be guided by intravascular imaging using optical coherence tomography OCT. Throughout the study, participants will be monitored at the time of the procedure and will have follow-up visits at 30 days, 1 year, and 2 years after treatment. Researchers will assess the final stent expansion using OCT during the procedure and evaluate procedural and strategy success. Safety and effectiveness of each lesion preparation method will be closely observed during these visits.
CONDITIONS
The Value of IVL Compared To OPN Non-Compliant Balloons for Treatment of RefractorY Coronary Lesions (VICTORY) Trial
F
Florim Cuculi, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Luzerner Kantonsspital
Lead Sponsor
Hôpital Fribourgeois
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of procedure
Participants undergo lesion preparation using either the Shockwave™ IVL balloon catheter or the super high-pressure PCI balloon OPN™ NCB, followed by implantation of a drug-eluting stent to treat heavily calcified coronary lesions.
1 procedure visit (in-person)
Duration - Up to 2 years
Participants are followed up to assess stent expansion and safety after the procedure.
Visits at 30 days, 1 year, and 2 years (in-person)
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Natalia Pinilla-Echeverri, Matthias Bossard, Ali Hillani...
https://pubmed.ncbi.nlm.nih.gov/36907698/Florim Cuculi, Matthias Bossard, Wojciech Zasada...
https://pubmed.ncbi.nlm.nih.gov/32076567/Thomas Seiler, Adrian Attinger-Toller, Giacomo Maria Cioffi...
https://pubmed.ncbi.nlm.nih.gov/36085285/Luzerner Kantonsspital
Lead Sponsor
Hôpital Fribourgeois
Collaborating Sponsor